miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1
Zhou, Guohua, Zhang, Fangli, Guo, Yu, Huang, Jianfei, Xie, Yaqiong, Yue, Shuanglei, Chen, Minghui, Jiang, Hao, Li, MengjieVolume:
85
Language:
english
Journal:
Biomedicine & Pharmacotherapy
DOI:
10.1016/j.biopha.2016.11.100
Date:
January, 2017
File:
PDF, 1.58 MB
english, 2017